Ownership
Private
Employees
~50
Therapeutic Areas
OncologyInfectious Diseases
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Botanical extractsHomeopathic preparations

Avila Herbals General Information

Avila Herbals has conducted clinical investigations that were cited in FDA warning letters for procedural issues. The company has developed oleander-based products and has agreements with Phoenix Biotechnology for manufacturing and R&D.

Drug Pipeline

No pipeline data available

For full access to Avila Herbals's pipeline data

Book a demo

Key Partnerships

Phoenix Biotechnology (exclusive global manufacturing and R&D agreements)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Avila Herbals Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Avila Herbals's complete valuation and funding history, request access »

Avila Herbals Financial Metrics